An Investigation on the Therapeutic Effect of Thymosin 4 and Its Expression Levels in Streptozotocin-Induced Diabetic Mice

Figure 1

Body weights and blood glucose levels of control and streptozotocin- (STZ-) induced diabetic mice. C57BL6J mice (n=9) were intraperitoneally injected with STZ (50 mg/kg/day) for 5 consecutive days. The body weight (a) and blood glucose level (b) were measured every 7 days and compared with the control group (n=6). There were significant differences between the two groups. P<0.05.

(a)

(b)